Silexion Therapeutics Corp (SLXN): SCHEDULE 13D/A filed Sep 28, 2026

Form type
SCHEDULE 13D/A
Filing date
Sep 28, 2026
Accession number
0001213900-26-104066
Filer
Silexion Therapeutics Corp (CIK 2022416)